Inovio Pharmaceuticals
INO
INO
182 hedge funds and large institutions have $201M invested in Inovio Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
-2
Holders Change %
-1.09%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
58
Reduced
39
Closed
25
Calls
$2.42M
Puts
$2.57M
Net Calls
-$146K
Net Calls Change
+$536K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$3.62M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$26.5M |
| 3 |
3
BlackRock
New York
|
$37.2M |
| 4 |
4
D.E. Shaw & Co
New York
|
$13M |
| 5 |
5
Barclays
London,
United Kingdom
|
$2M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$44.9M |
| 2 |
2
Two Sigma Investments
New York
|
$3.28M |
| 3 |
3
Morgan Stanley
New York
|
$2.23M |
| 4 |
4
Norges Bank
Oslo,
Norway
|
$0 |
| 5 |
5
Two Sigma Advisers
New York
|
$3.9M |
